ニューヨークにおける皮膚筋炎の臨床試験
ニューヨーク内の拠点で、皮膚筋炎に関する6件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Great Neck
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/09/24更新 · NCT06455449Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Hospital for Special Surgery - Accepting Adult and Juvenile Patients, New York
- Memorial Sloan Kettering Cancer Center - Accepting Adult and Juvenile Patients, New York
- Children's Hospital at Montefiore - Accepting Young Adult and Juvenile Patients, The Bronx
被験者募集中第2/3相
6歳〜75歳 · 全性別 · 2026/09/17更新 · NCT06154252A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- NYU Langone Health - Clinical and Translational Science Institute Research Pharmacy, New York
- NYU Langone Health Clinical Research Center, New York
- NYU Langone Health, New York
- 他3件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT05895786A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Icahn School of Medicine at Mount Sinai, New York
被験者募集中第1相
18歳〜74歳 · 全性別 · 2026/09/10更新 · NCT07085104Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/09更新 · NCT07138898ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。